<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="editorial">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ANG</journal-id>
<journal-id journal-id-type="hwp">spang</journal-id>
<journal-id journal-id-type="nlm-ta">Angiology</journal-id>
<journal-title>Angiology</journal-title>
<issn pub-type="ppub">0003-3197</issn>
<issn pub-type="epub">1940-1574</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0003319712455686</article-id>
<article-id pub-id-type="publisher-id">10.1177_0003319712455686</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Editorial</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Is There Any Association Between Adiponectin Gene Polymorphisms and Cardiovascular Disease?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Anagnostis</surname>
<given-names>Panagiotis</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319712455686">1</xref>
<xref ref-type="corresp" rid="corresp1-0003319712455686"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Athyros</surname>
<given-names>Vasilios G.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0003319712455686">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kita</surname>
<given-names>Marina</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319712455686">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Karagiannis</surname>
<given-names>Asterios</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0003319712455686">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-0003319712455686">
<label>1</label>Department of Endocrinology, Hippokration Hospital, Thessaloniki, Greece</aff>
<aff id="aff2-0003319712455686">
<label>2</label>Second Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, Greece</aff>
<author-notes>
<corresp id="corresp1-0003319712455686">Panagiotis Anagnostis, Department of Endocrinology, Hippokration Hospital, 49 Konstantinoupoleos, Thessaloniki 54642, Greece. Email: <email>anagnwstis.pan@yahoo.gr</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2013</year>
</pub-date>
<volume>64</volume>
<issue>4</issue>
<fpage>253</fpage>
<lpage>256</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>In this issue of <italic>Angiology</italic>, Rizk et al assess the association of adiponectin gene polymorphisms and, in particular, rs2241766 (+T45G) and rs1501299 (+G276T), with adiponectin levels and with the risk of acute coronary syndrome (ACS) in an Arabian cohort of Qatar.<sup>
<xref ref-type="bibr" rid="bibr1-0003319712455686">1</xref>
</sup> Despite the study’s limitations, such as the small sample size, the small proportion of females, and its cross-sectional nature, the authors concluded that only the single-nucleotide polymorphism (SNP) T45G (and not SNP G276T) was associated with ACS. Among the various genotypes of T45G, the GG carriers were associated with a higher risk of developing an ACS and having lower adiponectin levels. Some parameters were also addressed, such as diabetes mellitus (DM), number of blood vessels affected, and the ejection fraction status in ACS, but no association with the genotype distributions of T45G or G276T polymorphisms was found, except for EF with T45G.<sup>
<xref ref-type="bibr" rid="bibr1-0003319712455686">1</xref>
</sup>
</p>
<p>This editorial considers some additional aspects of this topic.</p>
<sec id="section1-0003319712455686">
<title>Adiponectin and Cardiometabolic Risk</title>
<p>Adiponectin is a 30-kDa protein secreted by mature adipocytes. It belongs to the soluble collagen superfamily, exerting structural homology with collagen VIII and X, complement factor C1q, and the tumor necrosis factor family.<sup>
<xref ref-type="bibr" rid="bibr2-0003319712455686">2</xref>
</sup> It is composed of a carboxyl-terminal globular domain and an amino-terminal collagenous domain, a structure that facilitates the formation of multimers. These include low-molecular-weight trimers, middle-molecular-weight 6-mers, and high-molecular-weight (HMW) 18-mers.<sup>
<xref ref-type="bibr" rid="bibr2-0003319712455686">2</xref>
</sup>
</p>
<p>Adiponectin seems to play a key role in the atherosclerotic process, since it inhibits monocyte adhesion to endothelial cells and suppresses lipid accumulation in human monocyte-derived macrophages, thus inhibiting macrophage-to-foam cell transformation.<sup>
<xref ref-type="bibr" rid="bibr3-0003319712455686">3</xref>
</sup> Adiponectin also exerts anti-inflammatory and insulin-sensitizing properties.<sup>
<xref ref-type="bibr" rid="bibr2-0003319712455686">2</xref>,<xref ref-type="bibr" rid="bibr4-0003319712455686">4</xref>
</sup> It acts through its receptors AdipoR1 and AdipoR2, in muscle and liver, respectively, stimulating adenosine monophosphate–activated protein kinase and the peroxisome proliferator–activated receptor-α pathways.<sup>
<xref ref-type="bibr" rid="bibr2-0003319712455686">2</xref>,<xref ref-type="bibr" rid="bibr4-0003319712455686">4</xref>
</sup> It increases fatty acid oxidation, reduces circulating free fatty acids, and prevents insulin resistance.<sup>
<xref ref-type="bibr" rid="bibr4-0003319712455686">4</xref>
</sup>
</p>
<p>Its levels are reduced in patients with type 2 DM and insulin resistance (compared with participants with normal glucose tolerance), as well as in those with coronary artery disease (CAD), nonalcoholic fatty liver disease, obesity, and high load of cardiometabolic risk factors.<sup>
<xref ref-type="bibr" rid="bibr2-0003319712455686">2</xref>,<xref ref-type="bibr" rid="bibr4-0003319712455686">4</xref>,<xref ref-type="bibr" rid="bibr5-0003319712455686">5</xref>
</sup> A positive association between high-density lipoprotein cholesterol (HDL-C) and adiponectin levels and an inverse relationship with homeostatic model assessment insulin resistance (HOMA-IR) have been reported.<sup>
<xref ref-type="bibr" rid="bibr5-0003319712455686">5</xref>
</sup> Adiponectin is the only adipokine that is downregulated in obesity.<sup>
<xref ref-type="bibr" rid="bibr2-0003319712455686">2</xref>
</sup> The HMW adiponectin has also been inversely associated with the extent of atherosclerosis in males. Its levels are downregulated in patients with metabolic syndrome (MetS) and type 2 DM.<sup>
<xref ref-type="bibr" rid="bibr2-0003319712455686">2</xref>
</sup> However, current evidence is not definitive enough to establish HMW as a better cardiometabolic risk marker than total adiponectin levels.<sup>
<xref ref-type="bibr" rid="bibr6-0003319712455686">6</xref>
</sup>
</p>
<p>Most studies show an inverse association between adiponectin levels and incidence of CAD. This is more evident in patients with low risk for cardiovascular disease (CVD).<sup>
<xref ref-type="bibr" rid="bibr2-0003319712455686">2</xref>,<xref ref-type="bibr" rid="bibr6-0003319712455686">6</xref>
</sup> On the other hand, some studies in patients with high CVD risk or established CAD have reported higher total adiponectin levels to be associated with higher mortality.<sup>
<xref ref-type="bibr" rid="bibr6-0003319712455686">6</xref>
</sup> Except for the differences in the population characteristics, statistical adjustments, and analytical methods used in these studies, the higher levels of adiponectin in patients with high risk of CVD may be a compensatory physiological response to prevent endothelial damage.<sup>
<xref ref-type="bibr" rid="bibr6-0003319712455686">6</xref>,<xref ref-type="bibr" rid="bibr7-0003319712455686">7</xref>
</sup>
</p>
</sec>
<sec id="section2-0003319712455686">
<title>Adiponectin Gene Polymorphisms and Risk for DM and MetS</title>
<p>The genetic basis of adiponectin levels has been thoroughly investigated during the last decade. The adiponectin (ADIPOQ) gene has been mostly studied and several SNPs have been identified. The most robust association between adiponectin levels and ADIPOQ locus that has emerged involves the variants −11391 G/A (rs17300539), −11377 C/G (rs266729), and −11426A&gt;G (rs16861194) located in the promoter region, the +45 T/G (rs2241766) variant in exon 2, the +276 G/T (rs1501299) variant in intron 2 and the +2019 single-nucleotide insertion/deletion polymorphism in the 3′ untranslated region.<sup>
<xref ref-type="bibr" rid="bibr6-0003319712455686">6</xref>,<xref ref-type="bibr" rid="bibr8-0003319712455686">8</xref>,<xref ref-type="bibr" rid="bibr9-0003319712455686">9</xref>
</sup>
</p>
<p>Several studies linked the aforementioned polymorphisms of ADIPOQ with the risk of CAD and type 2 DM in various populations. Studies from Asian populations have shown that SNP45GG genotype or G allele was a predictor of type 2 DM in Chinese and Japanese populations.<sup>
<xref ref-type="bibr" rid="bibr9-0003319712455686">9</xref>,<xref ref-type="bibr" rid="bibr10-0003319712455686">10</xref>
</sup> There are inconsistent data about the SNP276G allele, since an association with increased risk of type 2 DM in Japanese<sup>
<xref ref-type="bibr" rid="bibr10-0003319712455686">10</xref>
</sup> and in the elderly individuals from Taiwan<sup>
<xref ref-type="bibr" rid="bibr11-0003319712455686">11</xref>
</sup> has been reported, but others found no association.<sup>
<xref ref-type="bibr" rid="bibr12-0003319712455686">12</xref>
</sup> Some studies have also shown that SNP-11377GG genotype, SNP45G allele, SNP276GG genotype, and SNP712GG genotype might be a risk factor for dyslipidemia as they were associated with higher triglycerides (TGs), higher low-density lipoprotein cholesterol, lower HDL-C, and higher total cholesterol.<sup>
<xref ref-type="bibr" rid="bibr9-0003319712455686">9</xref>
</sup> Regarding atherosclerosis, SNP-11377GG and SNP45TG+GG genotypes have been associated with increased carotid artery intima–media thickness in type 2 DM.<sup>
<xref ref-type="bibr" rid="bibr9-0003319712455686">9</xref>
</sup> The association of ADIPOQ variants with insulin resistance was also reported in European cohorts. In particular, SNP +276G&gt;T but not SNP +45T&gt;G was associated with higher fasting insulin levels and HOMA-IR in nondiabetic Greek women, an effect which was evident in those with higher body fat status.<sup>
<xref ref-type="bibr" rid="bibr13-0003319712455686">13</xref>
</sup> Both ADIPOQ −11377GG and −11391GA variants have also been associated with increased risk of central obesity (odds ratio [OR]: 5.57 and OR: 3.37, respectively) in a recent study of a young European population. Both −11377C&gt;G and −11391G&gt;A variants were also significantly associated with the incidence of MetS and high TG levels in the same study.<sup>
<xref ref-type="bibr" rid="bibr14-0003319712455686">14</xref>
</sup>
</p>
<p>The ADIPOQ +45T&gt;G polymorphism and in particular the +45G allele (TG + GG) was significantly associated with increased risk of MetS (OR = 1.88, 95% confidence interval [CI]: 1.03-3.44, <italic>P</italic> = .039), independent of multiple confounders, in a recent study in a population of same origin (Asian)<sup><xref ref-type="bibr" rid="bibr15-0003319712455686">15</xref></sup> as in the present study by Rizk et al.<sup>
<xref ref-type="bibr" rid="bibr1-0003319712455686">1</xref>
</sup> Nevertheless, in a recent multiethnic population study (Diabetes Prevention Program), despite the strong independent associations of some ADIPOQ SNPs, such as rs17366568, rs1648707, rs17373414, and rs1403696, with adiponectin concentrations, none of them were directly related to the incidence of DM. However, 2 ADIPOR1 SNPs (rs1342387 and rs12733285) were associated with 18% increased DM incidence for carriers of the minor allele.<sup>
<xref ref-type="bibr" rid="bibr16-0003319712455686">16</xref>
</sup>
</p>
</sec>
<sec id="section3-0003319712455686">
<title>Adiponectin Gene Polymorphisms and CVD</title>
<p>Except for the association of ADIPOQ variants with the risk of DM or MetS, there are several studies reporting associations of these polymorphisms with the risk of CVD (mainly CAD and stroke). In contrast to the findings of Rizk et al in this issue of <italic>Angiology</italic>,<sup>
<xref ref-type="bibr" rid="bibr1-0003319712455686">1</xref>
</sup> larger studies from European<sup>
<xref ref-type="bibr" rid="bibr17-0003319712455686">17</xref>
</sup> and Asian<sup>
<xref ref-type="bibr" rid="bibr18-0003319712455686">18</xref>
</sup> populations have found that the SNP +276G&gt;T (but not SNP +45T&gt;G or other SNPs) was associated with CAD. In particular, in a large Italian cohort, TT homozygotes had half the risk of either myocardial infarction alone or myocardial infarction in association with type 2 DM (OR = 0.58, <italic>P</italic> = 0.01, and OR = 0.55, <italic>P</italic> = 0.006, respectively), when compared with the carriers of the G allele<sup><xref ref-type="bibr" rid="bibr17-0003319712455686">17</xref></sup>; while in a Japanese cohort the GG genotype was significantly associated with CVD, even after adjustment for traditional risk factors (OR = 1.66 with 95% CI 1.13-2.43, <italic>P</italic> = 0,0098).<sup>
<xref ref-type="bibr" rid="bibr18-0003319712455686">18</xref>
</sup> In contrast, a study in a Chinese population showed that of the 3 SNPs [rs266729 (−11377C/G), rs2241766 (+45T/G), rs1501299 (+276G/T)] of the <italic>ADIPOQ</italic> gene, only the rs266729 and in particular the GG genotype was associated with an increased the risk of ischemic stroke.<sup>
<xref ref-type="bibr" rid="bibr19-0003319712455686">19</xref>
</sup> Similar results as Rizk et al<sup><xref ref-type="bibr" rid="bibr1-0003319712455686">1</xref></sup> regarding the association of +45T&gt;G (rs2241766) and the G allele with increased risk of CAD (OR: 2.45, 95% CI: 1.05-6.04, <italic>P</italic> = .04) were obtained from a recent study in Brazilian participants with or without DM, although it was associated with higher levels of total and HMW adiponectin.<sup>
<xref ref-type="bibr" rid="bibr20-0003319712455686">20</xref>
</sup> The authors of this study found that the G allele of +276G&gt;T (rs1501299) was also associated with increased risk of CAD. These associations were independent of circulating levels of adiponectin.<sup>
<xref ref-type="bibr" rid="bibr20-0003319712455686">20</xref>
</sup>
</p>
<p>Two recent meta-analyses addressed the association of adiponectin gene polymorphisms with the risk of CVD, which yielded similar results for +45T/G. The first one (including 4394 cases/8187 controls) showed a significant association between −11377C/G polymorphism and CAD (G vs C: OR = 1.15, 95% CI: 1.07-1.24) both for European and East Asian populations, without any association with +45T/G or +276G/T SNPs.<sup>
<xref ref-type="bibr" rid="bibr21-0003319712455686">21</xref>
</sup> Another meta-analysis including data from 12 465 participants from 17 case–control studies revealed an increased risk of CAD for rs266729 and rs822395 SNPs and a reduced risk of CAD for rs1501299 SNP. In the stratified analysis, significant associations were found in Asian participants for rs266729 and in Caucasian participants for rs1501299. However, no association with the risk of CAD was found for rs2241766 (+45T/G).<sup>
<xref ref-type="bibr" rid="bibr22-0003319712455686">22</xref>
</sup> These results were confirmed by another recent meta-analysis of case–control studies in the Chinese Han population which suggested that the SNP+45T&gt;G was not associated with CAD, in contrast to SNP+276T allele which might be associated with decreased risk of CAD.<sup>
<xref ref-type="bibr" rid="bibr23-0003319712455686">23</xref>
</sup> In contrast, in another meta-analysis of studies from the same population the SNP+45T&gt;G and in particular the G allele showed a trend toward an increased risk of type 2 DM, without any association with SNP+276.<sup>
<xref ref-type="bibr" rid="bibr24-0003319712455686">24</xref>
</sup> Finally, in another meta-analysis, only the G allele of −11377C&gt;G (rs266729) was a risk factor for type 2 DM in white populations.<sup>
<xref ref-type="bibr" rid="bibr25-0003319712455686">25</xref>
</sup>
</p>
</sec>
<sec id="section4-0003319712455686">
<title>Conclusions</title>
<p>The aforementioned data indicate that ADIPOQ variants are promising markers for understanding the genetic basis of obesity-related disorders and CVD risk through adiponectin levels. There is no enough evidence at the moment for a significant association of the SNP+45T&gt;G with increased risk of CAD, despite the fact that an increased risk of type 2 DM cannot be excluded. However, the data are still inconsistent, mainly due to the differences in populations studied, and this necessitates the need for large prospective genetic studies with the consideration of gene–gene and gene–environment interactions, which will better elucidate and establish a potential prognostic value of adiponectin gene polymorphisms (especially T45G) in the development of CVD risk profile, irrespective of the presence of traditional confounders. These studies will also establish a more robust role for adiponectin levels as a surrogate biological marker for safer cardiovascular prognosis.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict" id="fn1-0003319712455686">
<label>Declaration of Conflicting Interests</label>
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-0003319712455686">
<label>Funding</label>
<p>The authors received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0003319712455686">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rizk</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>El-Menyar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Marei</surname>
<given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>Association of adiponectin gene polymorphism (+T45G) with acute coronary syndrome and circulating adiponectin levels</article-title>. <source>Angiology</source>. <year>2013</year>; <volume>64</volume>(<issue>4</issue>): <fpage>257</fpage>–<lpage>265</lpage>.</citation>
</ref>
<ref id="bibr2-0003319712455686">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Athyros</surname>
<given-names>VG</given-names>
</name>
<name>
<surname>Tziomalos</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Karagiannis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Anagnostis</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mikhailidis</surname>
<given-names>DP</given-names>
</name>
</person-group>. <article-title>Should adipokines be considered in the choice of the treatment of obesity-related health problems?</article-title> <source>Curr Drug Targets</source>. <year>2010</year>;<volume>11</volume>(<issue>1</issue>):<fpage>122</fpage>–<lpage>135</lpage>.</citation>
</ref>
<ref id="bibr3-0003319712455686">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ouchi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kihara</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Arita</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages</article-title>. <source>Circulation</source>. <year>2001</year>;<volume>103</volume>(<issue>8</issue>):<fpage>1057</fpage>–<lpage>1063</lpage>.</citation>
</ref>
<ref id="bibr4-0003319712455686">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shehzad</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Iqbal</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Shehzad</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>YS</given-names>
</name>
</person-group>. <article-title>Adiponectin: regulation of its production and its role in human diseases</article-title>. <source>Hormones (Athens)</source>. <year>2012</year>;<volume>11</volume>(<issue>1</issue>):<fpage>8</fpage>–<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr5-0003319712455686">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wolfson</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Gavish</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Matas</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Boaz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shargorodsky</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Relation of adiponectin to glucose tolerance status, adiposity, and cardiovascular risk factor load</article-title>. <source>Exp Diabetes Res</source>. <year>2012</year>;<fpage>2012</fpage>:<volume>250621</volume>.</citation>
</ref>
<ref id="bibr6-0003319712455686">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliveira</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Giuffrida</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Crispim</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Saddi-Rosa</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Reis</surname>
<given-names>AF</given-names>
</name>
</person-group>. <article-title>ADIPOQ and adiponectin: the common ground of hyperglycemia and coronary artery disease?</article-title> <source>Arq Bras Endocrinol Metabol</source>. <year>2011</year>;<volume>55</volume>(<issue>7</issue>):<fpage>446</fpage>–<lpage>454</lpage>.</citation>
</ref>
<ref id="bibr7-0003319712455686">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cook</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Semple</surname>
<given-names>RK</given-names>
</name>
</person-group>. <article-title>Hypoadiponectinemia—cause or consequence of human “insulin resistance”?</article-title> <source>J Clin Endocrinol Metab</source>. <year>2010</year>;<volume>95</volume>(<issue>4</issue>):<fpage>1544</fpage>–<lpage>1554</lpage>.</citation>
</ref>
<ref id="bibr8-0003319712455686">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kyriakou</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Spencer-Jones</surname>
<given-names>NJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Adiponectin gene ADIPOQ SNP associations with serum adiponectin in two female populations and effects of SNPs on promoter activity</article-title>. <source>J Hum Genet</source>. <year>2008</year>;<volume>53</volume>(<issue>8</issue>):<fpage>718</fpage>–<lpage>727</lpage>.</citation>
</ref>
<ref id="bibr9-0003319712455686">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>Y</given-names>
</name>
</person-group>. <article-title>The association studies of ADIPOQ with type 2 diabetes mellitus in Chinese populations [published online April 27, 2012]</article-title>. <source>Diabetes Metab Res Rev</source>. <year>2012</year>.</citation>
</ref>
<ref id="bibr10-0003319712455686">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hara</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Boutin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population</article-title>. <source>Diabetes</source>. <year>2002</year>;<volume>51</volume>
<issue>(2)</issue>:<fpage>536</fpage>–<lpage>540</lpage>.</citation>
</ref>
<ref id="bibr11-0003319712455686">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>CL</given-names>
</name>
<etal/>
</person-group>. <article-title>Adiponectin SNP276 is associated with obesity, the metabolic syndrome, and diabetes in the elderly</article-title>. <source>Am J Clin Nutr</source>. <year>2007</year>;<volume>86</volume>
<issue>(2)</issue>:<fpage>509</fpage>–<lpage>513</lpage>.</citation>
</ref>
<ref id="bibr12-0003319712455686">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Association study of the single nucleotide polymorphisms in adiponectin-associated genes with type 2 diabetes in Han Chinese</article-title>. <source>J Genet Genomics</source>. <year>2009</year>;<volume>36</volume>
<issue>(7)</issue>:<fpage>417</fpage>–<lpage>423</lpage>.</citation>
</ref>
<ref id="bibr13-0003319712455686">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melistas</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mantzoros</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Kontogianni</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Antonopoulou</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ordovas</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Yiannakouris</surname>
<given-names>N</given-names>
</name>
</person-group>. <article-title>Association of the +45T&gt;G and +276G&gt;T polymorphisms in the adiponectin gene with insulin resistance in nondiabetic Greek women</article-title>. <source>Eur J Endocrinol</source>. <year>2009</year>;<volume>161</volume>(<issue>6</issue>):<fpage>845</fpage>–<lpage>852</lpage>.</citation>
</ref>
<ref id="bibr14-0003319712455686">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karmelić</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Lovrić</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Božina</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Adiponectin level and genevariability are obesity and metabolic syndrome markers in a young population</article-title>. <source>Arch Med Res</source>. <year>2012</year>;<volume>43</volume>(<issue>2</issue>):<fpage>145</fpage>–<lpage>153</lpage>.</citation>
</ref>
<ref id="bibr15-0003319712455686">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>D</given-names>
</name>
<name>
<surname>He</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Association of the adiponectingene (ADIPOQ) +45 T &gt; G polymorphism with the metabolic syndrome among Han Chinese in Sichuan province of China</article-title>. <source>Asia Pac J Clin Nutr</source>. <year>2012</year>;<volume>21</volume>(<issue>2</issue>):<fpage>296</fpage>–<lpage>301</lpage>.</citation>
</ref>
<ref id="bibr16-0003319712455686">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mather</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Christophi</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Jablonski</surname>
<given-names>KA</given-names>
</name>
<etal/>
</person-group>. <article-title>For the Diabetes Prevention Program Research Group. Common variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/2), adiponectin concentrations, and diabetes incidence in the Diabetes Prevention Program [published online March 24, 2012]</article-title>. <source>Diabet Med</source>. <year>2012</year>.</citation>
</ref>
<ref id="bibr17-0003319712455686">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiodini</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Specchia</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gori</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>GISSI Prevenzione Investigators. SiBioC-GISSI Prevenzione Group. Adiponectingene polymorphisms and their effect on the risk of myocardial infarction and type 2 diabetes: an association study in an Italian population</article-title>. <source>Ther Adv Cardiovasc Dis.</source> <year>2010</year>;<volume>4</volume>(<issue>4</issue>):<fpage>223</fpage>–<lpage>230</lpage>.</citation>
</ref>
<ref id="bibr18-0003319712455686">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katakami</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kaneto</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Matsuoka</surname>
<given-names>TA</given-names>
</name>
<etal/>
</person-group>. <article-title>Adiponectin G276T gene polymorphism is associated with cardiovascular disease in Japanese patients with type 2 diabetes</article-title>. <source>Atherosclerosis</source>. <year>2012</year>;<volume>220</volume>
<issue>(2</issue>):<fpage>437</fpage>–<lpage>442</lpage>.</citation>
</ref>
<ref id="bibr19-0003319712455686">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Association of adiponectin gene polymorphisms with the risk of ischemic stroke in a Chinese Han population</article-title>. <source>Mol Biol Rep</source>. <year>2011</year>;<volume>38</volume>(<issue>3</issue>):<fpage>1983</fpage>–<lpage>1988</lpage>.</citation>
</ref>
<ref id="bibr20-0003319712455686">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliveira</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Saddi-Rosa</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Crispim</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Association of ADIPOQ variants, total and high molecular weight adiponectin levels with coronary artery disease in diabetic and non-diabetic Brazilian subjects</article-title>. <source>J Diabetes Complications</source>. <year>2012</year>;<volume>26</volume>(<issue>2</issue>):<fpage>94</fpage>–<lpage>98</lpage>.</citation>
</ref>
<ref id="bibr21-0003319712455686">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Xi</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Association between adiponectin gene polymorphisms and coronary artery disease across different populations</article-title>. <source>Thromb Res</source>. <year>2012</year>;<volume>130</volume>(<issue>1</issue>):<fpage>52</fpage>–<lpage>57</lpage>.</citation>
</ref>
<ref id="bibr22-0003319712455686">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Association of ADIPOQ gene polymorphisms and coronary artery disease risk: a meta-analysis based on 12 465 subjects</article-title>. <source>Thromb Res</source>. <year>2012</year>;<volume>130</volume>(<issue>1</issue>):<fpage>58</fpage>–<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr23-0003319712455686">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>YW</given-names>
</name>
</person-group>. <article-title>A meta-analysis of the association of adiponectin gene polymorphisms with coronary heart disease in Chinese Han population</article-title>. <source>Clin Endocrinol (Oxf)</source>. <year>2012</year>;<volume>76</volume>(<issue>3</issue>):<fpage>358</fpage>–<lpage>364</lpage>.</citation>
</ref>
<ref id="bibr24-0003319712455686">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Association of adiponectin SNP+45 and SNP+276 with type 2 diabetes in Han Chinese populations: a meta-analysis of 26 case-control studies</article-title>. <source>PLoS One</source>. <year>2011</year>;<volume>6</volume>(<issue>5</issue>):<fpage>e19686</fpage>.</citation>
</ref>
<ref id="bibr25-0003319712455686">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>LY</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>QH</given-names>
</name>
<name>
<surname>Jiao</surname>
<given-names>ML</given-names>
</name>
<etal/>
</person-group>. <article-title>Associations between single-nucleotide polymorphisms (+45T&gt;G, +276G&gt;T, -11377C&gt;G, -11391G&gt;A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis</article-title>. <source>Diabetologia</source>. <year>2011</year>;<volume>54</volume>(<issue>9</issue>):<fpage>2303</fpage>–<lpage>2314</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>